Trial · NCT00475852
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of Rehospitalization Due to Heart Failure and All-Cause Mortality | Randomization to Day 30 | |
| Primary | Dyspnea Self-Assessment at 6 Hours After Initiation of Study Drug | 6 hours after initiation of study drug | Dyspnea symptoms were measured by patient self-assessed Likert scale at 6 hours after study drug initiation.The Likert scale is a 7-point ordinal categorical scale (the 7 categories are markedly better, moderately better, minimally better, unchanged, minimally worse, moderately worse, and markedly worse.) |
| Primary | Dyspnea Self-Assessment at 24 Hours After Initiation of Study Drug | 24 hours after study drug initiation | Dyspnea symptoms were measured by patient self-assessed Likert scale at 24 hours after study drug initiation. The Likert scale is a 7-point ordinal categorical scale (the 7 categories are markedly better, moderately better, minimally better, unchanged, minimally worse, moderately worse, and markedly worse.) |
| Secondary | Overall Well-Being Self-Assessment at 6 Hours After Initiation of Study Drug | 6 hours after study drug initiation | Overall well-being was measured by patient self-assessed Likert scale at 6 hours after study drug initiation. The Likert scale is a 7-point ordinal categorical scale (the 7 categories are markedly better, moderately better, minimally better, unchanged, minimally worse, moderately worse, and markedly worse.) |
| Secondary | Overall Well-Being Self-Assessment at 24 Hours After Initiation of Study Drug | 24 hours after study drug initiation | Overall well-being was measured by patient self-assessed Likert scale at 24 hours after study drug initiation. The Likert scale is a 7-point ordinal categorical scale (the 7 categories are markedly better, moderately better, minimally better, unchanged, minimally worse, moderately worse, and markedly worse.) |
| Secondary | Composite of Persistent or Worsening Heart Failure and All-Cause Mortality | Randomization to hospital discharge (up to Day 30) | Clinical manifestations of worsening or persistent decompensated heart failure were defined by at least one of the following: new, persistent or worsening: dyspnea, orthopnea, paroxysmal nocturnal dyspnea, edema, pulmonary basilar rales/crackles, jugular venous distension, renal hypoperfusion with no other apparent cause, or radiologic evidence of worsening heart failure. And was also defined by a new therapy specifically for the treatment of worsening or persistent decompensated heart failure. |
| Secondary | Number of Days Alive and Outside the Hospital | Randomization to Day 30 | |
| Secondary | Composite of Cardiovascular Rehospitalization and Cardiovascular Mortality | Randomization to Day 30 | |
| Other | All-Cause Mortality Through Day 30 | Randomization to Day 30 | All deaths were adjudicated by an independent Clinical Events Committee. |
| Other | All-Cause Mortality Through Day 180 | Randomization to Day 180 | All deaths were adjudicated by an independent Clinical Events Committee. |
| Other | Cardiovascular Mortality Through Day 30 | Randomization to Day 30 | All deaths were adjudicated by an independent Clinical Events Committee (CEC) and the cardiovascular deaths were classified by the CEC based on the primary causes. |
| Other | Number of Patients With Renal Impairment | Study drug initiation to Day 30 | Renal impairment was defined as a greater than 25% decrease from baseline in the Modification of Diet in Renal Disease calculated glomerular filtration rate. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00475852/registered